Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Yuliya Pepelyayeva, D.O.

Concepts (85)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Yuliya Pepelyayeva's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Yuliya Pepelyayeva has written about over time.
Autoimmune Diseases, 2 publications between 2015 and 2019, average publication date February 2017. Selenium, 2 publications between 2014 and 2020, average publication date February 2017. Immunity, Innate, 5 publications between 2013 and 2022, average publication date June 2017. Inflammation, 3 publications between 2015 and 2019, average publication date August 2017. Aminopeptidases, 6 publications between 2013 and 2022, average publication date August 2017. Minor Histocompatibility Antigens, 6 publications between 2013 and 2022, average publication date August 2017. Genetic Predisposition to Disease, 2 publications between 2017 and 2018, average publication date January 2018. Polymorphism, Single Nucleotide, 2 publications between 2017 and 2018, average publication date January 2018. Spondylitis, Ankylosing, 2 publications between 2017 and 2018, average publication date January 2018. Adaptive Immunity, 2 publications between 2017 and 2019, average publication date April 2018. Antigen Presentation, 2 publications between 2017 and 2019, average publication date April 2018. Histocompatibility Antigens Class I, 2 publications between 2017 and 2019, average publication date April 2018. T-Lymphocytes, Regulatory, 1 publications between 2018 and 2018, average publication date August 2018. Autoimmunity, 1 publications between 2019 and 2019, average publication date February 2019. Selenomethionine, 1 publications between 2020 and 2020, average publication date January 2020. Inflammasomes, 1 publications between 2022 and 2022, average publication date March 2022. Multiple Sclerosis, Chronic Progressive, 1 publications between 2023 and 2023, average publication date March 2023.

To see the data from this visualization as text, click here.
Pepelyayeva's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (85)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.